According to a recent study published by a US-based medical journal, China’s Covid-19 vaccine Sinopharm has successfully contained Covid-19. This detailed coverage from a late-stage trial appears for the first time in US medical literature. Feels good that finally, there’s some sense of transparency that prevailed in China speculated to be the origin of the virus but the last among the world power to come up with the vaccines that too with glitches.
According to the study published by the JAMA Network Open, a monthly open-access medical journal published by the American Medical Association, Sinopharm’s vaccine-making unit China National Biotec Group Co., prevented symptomatic infections by 72.8% and 78.1% with its two inactivated vaccines developed in line with the previously announced state-owned drugmaker. Here’s a quote from Association’s journal published on May 26, 2021.
“This prespecified interim analysis of a randomized clinical trial included 40382 participants who received at least one dose of a 2-dose inactivated vaccine series developed from either SARS-CoV-2 WIV04 (5 µg/dose) or HB02 (4 µg/dose) strains or aluminum hydroxide–only control, with a primary endpoint of the incidence of symptomatic Covid-19 at least 14 days after the second injection. The efficacy for the two vaccines, compared with aluminum hydroxide–only control, was 72.8% in the WIV04 group and 78.1% in the HB02 group; both comparisons were statistically significant.” JAMA Network
China Peddles Unapproved Sinovac via Sinopharm
Although it is hard to accept a snake offering an antidote to its own poison, the State-owned Sinopharm vaccine is not full and fair in its immunogenicity report for imbalanced male and female participation. Nonetheless, China has the approval of WHO to take risks with its population. But does this mean China has only one vaccine manufacturer that too a State-run? Well, Sinopharm has a peer, the private drug manufacturer Sinovac Biotech Ltd. They both are considered the leading resources for Covid-19 vaccinations in China today. Both these companies have also extended their distribution to poor and developing countries, including Hungary, Serbia, Seychelles, Peru, etc.
Seychelles and Chile see a Rise in Covid-19 after Sinovac
Compared to the Sinopharm vaccine that has the approval of the World Health Organization (WHO), the Sinovac vaccine has none as of May 27, 2021. Media reports expect a nod from WHO this week, closing in another three days while 380 million doses have been already distributed worldwide. Does that mean China’s megalomania approved the rollout of the Sinovac vaccine in developing countries without WHO’s permission? So Seychelles and Chile questioning the efficacy of the Chinese Covid-19 drug after a sizeable administration failing to contain a sudden spike deserves an answer from the Chinese government? Is this the reason behind the markets subjecting China’s generosity to heavy criticism for non-disclosure of the drug’s safety and efficacy?
Hong Kong Allows Unapproved Vaccine. Singapore Resists
Hong Kong has been fighting to stay away from China, but it is a duopoly system so far. The People’s Republic of China controls Hong Kong as its Special Administrative Region, allowing Hong Kong to have its autonomous law. So, this Hong Kong comes without any surprise, has waived the requirement for a peer-reviewed publication to approve the Sinovac vaccine earlier in 2021. However, regulators in Singapore have Moderna over Sinopharm or Sinovac as it demands more data.
WHO is Hallucinating?
As international pressure for more vaccine distribution rises, WHO seeks more data from Sinovac Biotech Ltd.’s CoronaVac before the nod due this week of May 24-30, 2021. There is a consideration if China should be approved of a second drug, which presents a different challenge; what about all the resources that went into the manufacturing of CoronaVac. WHO inquiring about the consumption safety of CoronaVac and Sinovac’s manufacturing compliance report after Seychelles and Chile have consumed and questioned the vaccine’s efficacy is like America, not WHO messing up intelligence.
Sinovac Refuses Covax
China is the least remorseful country in the world. Businesses or individuals have no remorse, no empathy other than their apparent showcase nicety. This is why Sinovac, as a Chinese manufacturing enterprise, has not agreed to contribute to the Covax initiative co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI), and WHO. It seems that Covax should not procure any vaccine manufactured in China or by China through bilateral investment and therefore really not be bothered about Sinovac that is desperate for killing people in developing countries without following any global standardization.
The Fauci Fibonacci
America’s leading pandemic expert and medical advisor to the White House, Dr. Fauci, is playing dubious in many ways. Firstly, under his supervision, JAMA publishes the Sinopharm study, which informs that the immunogenicity report is largely male-centric. And yet, he does not take it up with WHO to stop the Sinopharm vaccine until it is sufficiently tried on women to ensure unbiased effectiveness. Secondly, in 2020, Dr. Fauci dismissed the theory that the deadly Covid-19 virus that took the world to the death bed was genetically engineered at a lab in Wuhan, China. Thirdly, now Dr. Fauci tells Fox News, “I am not convinced about that, I think we should continue to investigate what went on in China until we continue to find out to the best of our ability what happened.”
America’s Trial with the Dimwits
Former President of the United States, Donald Trump, is not a polished human. He rash but had a clear take on China and its vicious bioweapon. When he called for a ban on China, people critiqued the dimwit Donny. President Joe Biden and VP Kamala Harris were also critical of Trump’s move. Trump was the requirement of the US military that actually runs America. Still, that system didn’t see the strategy holding up for long and thus made way for the Biden-Harris class of administration. Interestingly, as per media, President Biden once wants China to come clean on the origin of COVID-19 & the other time he shuts the State Dept inquiry?
‘redouble their efforts’
On May 26, 2021, a CNN report published the news of the Biden administration ending further inquiry into the origins of the novel coronavirus in a lab in Wuhan. The inquiry led by The State Department was launched by the office of President Donald Trump but suspended because of “concerns about the quality of its work.” There are many ways of looking at this. To us, it appears to be Dr. Fauci, on behalf of America, was commissioned to collaborate with China on a bioweapon and their fallout resulting in the leakage of the SARS-CoV-2 virus. And now, because China has retaliated to the earlier “redouble their efforts” as an exhibit of America’s interest in the fair investigation into the origin of the pandemic, Biden doesn’t want the water to flow any further. Sinovac or Sinopharm are mere distractions only.
Dear Reader,
First, thank you for your precious time reading the stories (without paywalls) I publish on Startups to Enterprises covering the EU, China, the US, and India. Second, I request you to contribute financially (any amount) to help me sustain this as an independent digital business news media.
If I receive a request for a sponsored post, I ensure I see merit that is meaningful for erudite and informed readers like you. In the bargain, I lose out on sponsorships wherein I need funds to sustain this effort. Your contribution helps me stay afloat.
Please note that your contribution is treated as revenue generated and not a donation; hence, there are no 80G or other donation certificates. In fact, as I am eligible to pay for the revenue generated, I will pay taxes on the same.
You deserve to know that I abide by journalistic ethics and practices to ensure I tell the stories as is, unbiased. You can follow us on Facebook, Linkedin, and Twitter, bookmark us on Google News, and finally, PayPal us here.
Founding Editor
Linda Ashok